Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia.
暂无分享,去创建一个
L. Moldawer | T. Huber | E. Copeland | J. Seeger | C. Solórzano | P. Edwards | T. Martin | P. Hess | T. Harward | M. Welborn | S. Duschek | Paul D. Edwards | Stephenie Duschek
[1] L. Moldawer,et al. VISCERAL ISCHEMIA‐REPERFUSION INJURY PROMOTES TUMOR NECROSIS FACTOR (TNF) AND INTERLEUKIN‐1 (IL‐1) DEPENDENT ORGAN INJURY IN THE MOUSE , 1996, Shock.
[2] E. Radwanski,et al. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. , 1996, Blood.
[3] T. Huber,et al. Operative mortality rates after elective infrarenal aortic reconstructions. , 1995, Journal of vascular surgery.
[4] E. Moore,et al. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. , 1994, Archives of surgery.
[5] M. Billah,et al. Interleukin-10 inhibits interleukin-8 production in human neutrophils. , 1994, Blood.
[6] F. Calzetti,et al. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation , 1994, The Journal of experimental medicine.
[7] E. Moore,et al. Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure. , 1994, The Journal of surgical research.
[8] A. Mantovani,et al. Divergent effects of interleukin‐10 on cytokine production by mononuclear phagocytes and endothelial cells , 1993, European journal of immunology.
[9] C. Valeri,et al. Neutrophil and Nonneutrophil‐Mediated Injury in Intestinal Ischemia‐Reperfusion , 1993, Annals of surgery.
[10] E. Moore,et al. Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11b adhesion. , 1993, Surgery.
[11] J. Horton,et al. Oxygen radicals, lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. , 1993, Journal of applied physiology.
[12] M. Howard,et al. Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.
[13] W. Fiers,et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia , 1993, The Journal of experimental medicine.
[14] T. Lindsay,et al. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. , 1992, Journal of immunology.
[15] E. Moore,et al. Phospholipase A2 inhibition decouples lung injury from gut ischemia-reperfusion. , 1992, Surgery.
[16] N. Hertzer,et al. Thoracoabdominal aneurysm repair: a representative experience. , 1992, Journal of vascular surgery.
[17] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[18] M. Donaldson,et al. Evolving experience with thoracoabdominal aortic aneurysm repair at a single institution. , 1991, Journal of vascular surgery.
[19] T. Mosmann,et al. The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991, Immunology today.
[20] D. Remick,et al. Evidence for Tumor Necrosis Factor‐induced Pulmonary Microvascular Injury After Intestinal Ischemia—Reperfusion Injury , 1990, Annals of surgery.
[21] R. Strieter,et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.
[22] W. Smead,et al. Clinical observations and lessons learned in the treatment of patients with thoracoabdominal aortic aneurysms. , 1988, Surgery, gynecology & obstetrics.
[23] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[24] U. Steckholzer,et al. Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. , 1996, Archives of surgery.
[25] M. Schepens,et al. Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping. Risk factors and late results. , 1994, The Journal of thoracic and cardiovascular surgery.
[26] K. Bienvenu,et al. Leukocyte adhesion in ischemia/reperfusion. , 1993, Blood cells.
[27] R. de Waal Malefyt,et al. Biological properties of interleukin 10. , 1992, Immunology today.